Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

10.05
+4.8492.90%
Pre-market: 9.19-0.8600-8.56%05:41 EDT
Volume:37.61M
Turnover:496.57M
Market Cap:11.29M
PE:-0.32
High:17.80
Open:15.00
Low:8.22
Close:5.21
Loading ...

HCW Biologics to Raise $6.9 Million in Gross Proceeds From Direct Offering, Private Placement; Shares Extend Gains Premarket

MT Newswires Live
·
19 Nov 2024

BRIEF-Hcw Biologics Prices $6.9 Mln Registered Direct Offering And Concurrent Private Placement At $1.03 Per Share

Reuters
·
19 Nov 2024

HCW Biologics Inc - Combined Effective Offering Price Set at $1.03 per Share

THOMSON REUTERS
·
19 Nov 2024

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules

THOMSON REUTERS
·
19 Nov 2024

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

GlobeNewswire
·
19 Nov 2024

Top Midday Gainers

MT Newswires Live
·
19 Nov 2024

HCW Biologics Shares Surge on License Agreement

Dow Jones
·
19 Nov 2024

Why Is Penny Stock HCW Biologics Surging On Monday?

Benzinga
·
18 Nov 2024

HCW Biologics, WY Biotech Sign License Deal for Immunotherapeutic Product Candidate

MT Newswires Live
·
18 Nov 2024

HCW Biologics jumps on license agreement for immunotherapeutic product candidate

seekingalpha
·
18 Nov 2024

HCW Biologics and Wy Biotech Announce License Agreement for Immunotherapeutic Product Candidate

THOMSON REUTERS
·
18 Nov 2024

HCW Biologics Inc - Is Eligible to Receive Additional Milestone Payments and Double-Digit Royalties on Future Product Sales

THOMSON REUTERS
·
18 Nov 2024

HCW Biologics Inc - to Receive $7 Million Upfront Payment

THOMSON REUTERS
·
18 Nov 2024

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

GlobeNewswire
·
18 Nov 2024